期刊文献+

重庆市1010例急性心肌梗死住院治疗状况分析 被引量:3

A retrospective survey of treatment status of 1 010 patients with acute myocardial infarction in Chongqing
下载PDF
导出
摘要 目的调查分析重庆地区急性心肌梗死(AMI)一般情况和临床治疗状况。方法回顾分析重庆市1 010例AMI住院病历,记录其一般情况、病史特征、诊断、治疗方式及药物使用情况。结果行经皮冠状动脉介入治疗(PCI)325例,占32.2%,直接PCI 91例,占9.0%,药物溶栓治疗122例,占12.1%;药物使用:肝素/低分子肝素86.6%,他汀类80.8%,硝酸酯类76.7%,阿司匹林90.1%,阿司匹林联用氯吡格雷74.7%,ACEI/ARB 74.2%,β受体阻滞剂55.1%;逐年比较,他汀类、阿司匹林、阿司匹林联用氯吡格雷及肝素/低分子肝素使用率有提高,ACEI/ARB和β受体阻滞剂的实际/适宜使用率呈增加趋势。结论重庆地区AMI早期再灌注治疗及药物治疗距《急性心肌梗死诊断和治疗指南》要求尚有差距。 Objective To document knowledge about the clinical characteristics and management of the patients with acute myo cardial infarction(AMI) in Chongqing. Methods The retrospective survey of 1 010 hospitalized patients with AMI in Chongqing was carried out. All the baseline data, medical history, diagnosis, treatment and drug use characteristics were collected and analyzed. Results Among these patients,32.2% underwent percutaneous coronary intervention (PCI), 9.0% underwent Primary PCI, and 12.1% received thrombolytic therapy. The rates of various medication employed in the 1 010 patients were: unfractionated heparin / LMWH 86.6 %, statins 80.8% , nitrates 76. 7 %, aspirin 90.1%, aspirin plus clopidogrel 74.7% , ACEI/ARB 74. 2 %,β-receptor blocker 55.1% . The utilization rates of statins,aspirin,aspirin plus clopidogrel and unfractionated heparin/LMWH were increased. The actual utilization to eligible utilization ratio of ACEI/ARB andβ-receptor blocker was increased. Conclusion There still exists a gap between earlier reper;usion treatment and drug therapy on AMI and guidelines in Chongqing.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第14期1710-1711,1714,共3页 Chongqing medicine
关键词 心肌梗死 治疗状况 再灌注治疗 myocardial infarction treatment status reperfusion
  • 相关文献

参考文献3

二级参考文献13

  • 1中国心脏研究(暨CEI-AMI研究)协作组.中国心脏研究: 卡托普利对急性心肌梗死患者早期病死率和并发症影响的多中心临床试验--全国大规模随机双盲安慰剂对照临床试验14962例总结[J].中华心血管病杂志,1997,25:245-251.
  • 2[1]Morice MC,Serruys PW,Sousa JE,et al.A randomized comparison of a sirolimus eluting stent with a standard stent for coronary revascularization.N Engl J Med,2002,346:1773-1780.
  • 3[2]Moses JW,Leon MB,Popma JJ,et al.Sirolimus eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med,2003,349:1315-1323.
  • 4[3]Ruygrok PN,Muller DW,Serruys PW.Rapamycin in cardiovascular medicine.Intern Med J,2003,33:103-109.
  • 5[4]Schofer J,Schluter M,Gershlick AH,et al.Sirolimus eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:double blind,randomized controlled trial (E-SIRIUS).Lancet,2003,362:1093-1099.
  • 6[5]Sousa JE,Costa MA,Sousa AG,et al.Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus eluting stents in human coronary arteries.Circulation,2003,107:381-383.
  • 7[6]Park SJ,Kim YH,Lee BK,et al.Sirolimus-eluting stent implantation for unprotected left main coronary artery stenosis:comparison with bare metal stent implantation.J Am Coll Cardiol,2005,45:351-356.
  • 8[7]Shafiq N,Malhotra S,Pandhi P,et al.A meta-analysis of clinical trials of paclitaxel-and sirolimus-eluting stents in patients with obstructive coronary artery disease.Br J Clin Pharmacol,2005,59:94-101.
  • 9北京地区冠心病协作组.北京地区急性心肌梗死1972—1983年住院病例的临床概况及发病趋势监测[J].中华心血管病杂志,1985,13:162-165.
  • 10陶寿淇.中华医学会第二届全国心血管病学术会议纪要[J].中华内科杂志,1983,22:710-713.

共引文献89

同被引文献17

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部